Global Nadolol Market Driven by Rising Demand for Cardiovascular Treatments
The global Nadolol Market is projected to grow significantly, reaching US$ 2.48 billion by 2034 from US$ 1.59 billion in 2025, registering a CAGR of 5.76% during the forecast period of 2026–2034. Nadolol, a non-selective beta-blocker widely prescribed for hypertension, angina pectoris, and certain cardiac rhythm disorders, continues to play a vital role in cardiovascular treatment...
0 Commenti 0 condivisioni 29 Views 0 Anteprima